PARADIMGS · CFTY720D2311
Ficha pública del estudio de investigación clínica neurológica. Consulte el estado actual de reclutamiento en la ficha actualizada desde Wix.
A two-year, double-blind, randomized, multicenter, active controlled study to evaluate the safety and efficacy of fingolimod administered orally once daily versus interferon β-1a i.m. once weekly in pediatric patients with multiple sclerosis with five-year fingolimod Extension Phase. EudraCT: 2011-005677-23
Promotor: NOVARTIS
Fase: III
Área: Neuroinmunología